Prima chairman on phenomenal stock performance
19 October, 2009 by Tim DeanLetter from chairman, Ata Gokyildirim, reflects on 2,900% gain in stock this year.
Australian biotech market watch 16/10/09
16 October, 2009 by Tim DeanBiota, Primary Health Care, ResMed, Acrux, Ansell
Adelaide to host AusBiotech 2011
16 October, 2009 by Tim DeanAnnual biotechnology conference to be held in the festival state.
Australian biotech market watch 14/10/09
14 October, 2009 by Tim DeanSirtex, QRxPharma, Biota, Ramsay Health Care, ResMed, CSL
Special feature: Top 10 clinical trial mistakes
14 October, 2009 by Staff WritersHere are 10 common clinical trial mistakes you should avoid.
Australian biotech market watch 09/10/09
09 October, 2009 by Tim DeanCSL, Primary Health Care, Cochlear, Blackmores, Ansell
Australian biotech market watch 07/10/09
07 October, 2009 by Tim DeanRamsay, Cochlear, pSivida, Ansell, Biota
Australian biotech market watch 02/10/09
02 October, 2009 by Tim DeanBiota, Ramsay, Cochlear, Blackmores, Clinuvel
CSL speaks out on vaccination 'myths'
01 October, 2009 by Tim DeanMyth busting panel dispels 'myths' surrounding the H1N1 swine flu vaccine.
Australian biotech market watch 30/09/09
30 September, 2009 by Staff WritersCochlear, Ansell, pSivida, Fisher & Paykel, Sonic Healthcare
Australian biotech market watch 28/09/09
28 September, 2009 by Staff WritersClinuvel Pharmaceuticals, Cellistis Limited, Acrux, CSL Limited
Bionomics in the money
08 September, 2009 by Tim Dean$15 million capital raising enough to fund trials for over two years.
Prima gets go ahead for ovarian cancer vaccine trial in US
02 September, 2009 by Tim DeanFDA gives clearance for Phase IIb trial of CVac vaccine in the US.
Sirtex profits up eightfold
28 August, 2009 by Tim DeanGains made through increased sales and currency movements.
Australian biotech market watch 28/08/09
28 August, 2009 by Tim DeanSonic, Sirtex, Blackmores, Healthscope, Cellestis
